chemotherapy

Open Access
Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer
DIRK RADES, TOBIAS BARTSCHT, ACHIM RODY, NATHAN Y. YU and MARTIN BALLEGAARD

Anticancer Research May 2025, 45 (5) 2123-2135; DOI: https://doi.org/10.21873/anticanres.17587
Open Access
Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
NOBUKI FURUBAYASHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, YUSHI FUJIMOTO, MOTONOBU NAKAMURA and TAKAHITO NEGISHI

Anticancer Research May 2025, 45 (5) 2185-2193; DOI: https://doi.org/10.21873/anticanres.17592
Open Access
Adjuvant Treatment for Resectable Pancreatic Cancer
TORU AOYAMA, KENTARO HARA, AYA SAITO and HARUHIKO CHO

Anticancer Research April 2025, 45 (4) 1329-1341; DOI: https://doi.org/10.21873/anticanres.17519
You have access
Does Aggressive Versus Less Aggressive Non-operative Treatment of Large and Very Large (≥7 cm) Lung Cancers Matter?
FEDERICO AMPIL, CARLOS PREVIGLIANO, KIM HEATH and AMY BOZEMAN

Anticancer Research April 2025, 45 (4) 1593-1598; DOI: https://doi.org/10.21873/anticanres.17540
You have access
A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203 HERBIS-5): Final Results
JUNJI KAWADA, DAISUKE SAKAI, YUTAKA KIMURA, MOTOHIRO HIRAO, KAZUHIRO NISHIKAWA, NAOTOSHI SUGIMOTO, YOSHIO OKA, SHUNJI ENDO, YUTAKA ISOZAKI, JIN MATSUYAMA, RYOHEI KAWABATA, TOMONO KAWASE, KAZUMASA FUJITANI, YUKINORI KUROKAWA, HISATO KAWAKAMI, TOSHIO SHIMOKAWA, TAROH SATOH and Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)

Anticancer Research March 2025, 45 (3) 1077-1085; DOI: https://doi.org/10.21873/anticanres.17495
Open Access
Outcomes of Scapular Osteosarcoma
LEILANI GARAYUA-CRUZ, SAMUEL E. BROIDA, STEVEN I. ROBINSON, SCOTT H. OKUNO, THANH P. HO, BRITTANY L. SIONTIS, COURTNEY E. SHERMAN, KRISTA A. GOULDING and MATTHEW T. HOUDEK

Anticancer Research January 2025, 45 (1) 219-223; DOI: https://doi.org/10.21873/anticanres.17407
You have access
Vascular Pain and Nurse Burden in Peripheral Administration of Fosaprepitant/Fosnetupitant: A Prospective Observational Study
YUKO KUBOTA, SHIRO HATAKEYAMA, SHUHEI SUZUKI, HIROKI SAWADA, YUKO SATO, TAKASHI YOSHIOKA and CHIKA OZAWA

Anticancer Research January 2025, 45 (1) 277-285; DOI: https://doi.org/10.21873/anticanres.17415
Open Access
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice
AKIKO TATEISHI, YUSUKE OKUMA, YASUSHI GOTO, MOTOKO ARAKAKI, YUKIKO SHIMODA IGAWA, MASAHIRO TORASAWA, YUKI SHINNO, TATSUYA YOSHIDA, HIDEHITO HORINOUCHI, NOBORU YAMAMOTO and YUICHIRO OHE

Anticancer Research December 2024, 44 (12) 5501-5513; DOI: https://doi.org/10.21873/anticanres.17376
Open Access
Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
SARA COCCHI, JOANNA LOPACINSKA-JØRGENSEN and ESTRID V. HØGDALL

Anticancer Research November 2024, 44 (11) 4691-4707; DOI: https://doi.org/10.21873/anticanres.17296
You have access
Synchronous Pancreatic Ductal Adenocarcinoma and Nasopharyngeal Carcinoma With Associated Novel Pathogenic ATM Mutation
LILY XU, AMANDA TIAN, RUOHAO FAN and JINPING LAI

Anticancer Research October 2024, 44 (10) 4605-4608; DOI: https://doi.org/10.21873/anticanres.17290

Main menu

User menu

Search

chemotherapy

Pages